Characterized by scaled manufacturing capacities, the production of Desano Pharma are equipped with state-of-the-art facilities as well as professional managerial team. Products are ranging from intermediates, active pharmaceutical ingredients to finished pharmaceutical products to satisfy the needs of various customers from emerging markets to highly regulated markets. The well organized and experienced manufacturing teams ensure the quality of products as shown by the successful execution of obtaining WHO prequalification and US FDA inspections.
API and Intermediates production
We have two intermediate manufacuturing sites and three API manufacuturing sites. Our annual intermediates capacity is 4000MT/year and annual API capacity is 1000MT year.
Number of reactors |
650 sets £¨ 20L ¡« 30000L £© |
Total volume of reactors |
1800m 3 |
Temperature/pressure |
-100 ¡« 300 ¡æ / 6.5MPa |
Number of fermentation reactors |
21 sets £¨ 500L -70000L £© |
Total volume of fermentation reactors |
590m 3 |
Area of clean room area workshops |
5000m 2 |
Formulation production
We have two formulation manufacturing sits with dosage forms of oral use (tablets, capsules, granules, powders), external use( solution, gels, cream, lotions), Huge volume Injection, Small volume Injection, Lyophilizer.
Tablets |
400,000,000/year |
Capsules |
100,000,000/year |
Small volume Injection, Lyophilizer |
200,000,000/year |
|